Deliberate
Pioneering AI and machine learning methods to improve diagnostics, objectively track progress and provide actionable insights for mental health treatment.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | - | |
| Total Funding | 000k | ||
| USD | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | 29 % | - |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Deliberate AI is at the forefront of revolutionizing mental healthcare and clinical trials through data-driven diagnostics and monitoring. The company addresses the challenges faced by clinicians and researchers in managing and interpreting patient data, especially when dealing with multiple systems and both remote and in-person patient interactions. Deliberate AI's solutions are designed to enhance the accuracy and reliability of clinical endpoints, which are the key outcomes used to determine the effectiveness of a treatment. This, in turn, improves signal detection, which is the ability to identify true treatment effects amidst the noise of imperfect data.
The company serves two primary types of clients: mental healthcare providers and organizations conducting clinical trials. In the mental healthcare sector, Deliberate AI empowers clinicians by providing tools for scientific measurement-based care, treatment recording analytics, and remote clinical assessments. This helps clinicians improve patient outcomes, save time, and increase revenue.
In the clinical trials market, Deliberate AI collaborates with leading academics and computer scientists to enhance endpoint accuracy and reliability. This collaboration translates breakthrough science into clinical impact by increasing study power, reducing the required sample sizes, and accelerating study completion. This optimization leads to more efficient and successful trials, ultimately speeding up the time to market for new treatments.
Deliberate AI operates on a business model that likely includes subscription-based services, software licensing, and possibly consulting fees. The company makes money by providing its advanced diagnostic and monitoring solutions to healthcare providers and research organizations, who benefit from improved data management and analysis capabilities.
Keywords: data-driven diagnostics, mental healthcare, clinical trials, endpoint accuracy, signal detection, patient outcomes, remote assessments, scientific measurement, treatment analytics, collaborative research.